BDX vs. GH: Becton, Dickinson vs. Guardant Health Stock Comparison

Company Profile

Becton, Dickinson (BDX) and Guardant Health (GH) both fall under the Health Care Equipment & Services industry group, but BDX is classified in Health Care Equipment & Supplies while GH is classified in Health Care Providers & Services.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Guardant Health (GH) has an aggressive beta of 1.69, indicating higher sensitivity to broad-market moves, while Becton, Dickinson (BDX) is defensive at 0.19 and tends to be less market-sensitive — they sit on opposite ends of the beta spectrum.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Capital efficiency shows on one side only: Becton, Dickinson (BDX) earns 5.66% on shareholders’ equity, ranked against its industry; Guardant Health (GH) has no ROE this period.

Guardant Health (GH) reports a negative net margin of -37.93%, usually indicating a net loss over the period. Meanwhile Becton, Dickinson (BDX) reports 5.89%, ranking against industry peers normally.

Guardant Health (GH) reports a negative operating margin of -37.06%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Becton, Dickinson (BDX) reports 21.63%, ranking against industry peers normally.

Profitability Metrics

Growth

Guardant Health (GH) at 32.88% sits in the top revenue growth quartile, while Becton, Dickinson (BDX) at 8.24% is closer to the peer norm — faster top-line expansion for GH.

Only one side can be read here: Becton, Dickinson (BDX) reports EPS growth of -1.86%, ranked against its industry; Guardant Health (GH) has no EPS growth figure this period.

Growth Metrics

Financial Strength

Guardant Health (GH) at 3.60 keeps current ratio within its industry’s typical mid-range, while Becton, Dickinson (BDX) at 0.87 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for BDX.

Only one side’s leverage can be read here: Becton, Dickinson (BDX) carries debt-to-equity ratio of 0.66 against its industry range, while Guardant Health (GH) reports no figure this period.

Financial Strength Metrics

Dividends

Neither Becton, Dickinson (BDX) nor Guardant Health (GH) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

Guardant Health (GH) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Becton, Dickinson (BDX) reports a payout of 72.49%, ranking against industry peers normally.

Dividend Metrics

Valuation

An earnings multiple is available for just one side: Becton, Dickinson (BDX) trades at 41.87 times trailing earnings, ranked against its peers, while Guardant Health (GH) has no P/E ratio this period.

Becton, Dickinson (BDX) at 2.97 prices around its industry’s typical P/S ratio, while Guardant Health (GH) at 15.96 clears its benchmark range — GH looks notably rich on sales.

Guardant Health (GH) reports a negative P/B ratio of -73.67, meaning negative book equity — the multiple itself is not meaningful for valuation. Meanwhile Becton, Dickinson (BDX) reports 2.34, ranking against industry peers normally.

Valuation Metrics